|
Volumn 327, Issue 7421, 2003, Pages 942-943
|
Topical corticosteroids in atopic dermatitis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BETAMETHASONE VALERATE;
CORTICOSTEROID;
EMOLLIENT AGENT;
FLUTICASONE;
HYDROCORTISONE;
IMMUNOMODULATING AGENT;
PIMECROLIMUS;
TACROLIMUS;
ANTIINFLAMMATORY AGENT;
GLUCOCORTICOID;
ANAPHYLAXIS;
ATOPIC DERMATITIS;
CLINICAL TRIAL;
DISEASE SEVERITY;
DRUG EFFECT;
DRUG EFFICACY;
DRUG POTENCY;
DRUG SAFETY;
EDITORIAL;
HUMAN;
PRIORITY JOURNAL;
RASH;
RECURRENCE RISK;
SIDE EFFECT;
SKIN ATROPHY;
SKIN MANIFESTATION;
SKINFOLD THICKNESS;
STEROID THERAPY;
STRIA;
TACHYPHYLAXIS;
TELANGIECTASIA;
TREATMENT OUTCOME;
CONTROLLED CLINICAL TRIAL;
LETTER;
RANDOMIZED CONTROLLED TRIAL;
TOPICAL DRUG ADMINISTRATION;
ADMINISTRATION, TOPICAL;
ANTI-INFLAMMATORY AGENTS;
DERMATITIS, ATOPIC;
GLUCOCORTICOIDS;
HUMANS;
RANDOMIZED CONTROLLED TRIALS;
TREATMENT OUTCOME;
|
EID: 0142216247
PISSN: 09598146
EISSN: None
Source Type: Journal
DOI: 10.1136/bmj.327.7421.942 Document Type: Editorial |
Times cited : (49)
|
References (7)
|